Primary record
Silmitasertib, 98%, a potent and selective ATP-competitive CK2 inhibitor - 25MG 25mg
- 库存
- 2,016 克
- 纯度
- 98.9 %
- CAS
- 1009820-21-6
化合物标识与属性
- CAS
- 1009820-21-6
- PubChem CID
- 24748573
- SMILES
- C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4
- Canonical SMILES
- O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12
名称与同义词
- Silmitasertib
- 1009820-21-6
- CX-4945
- silmitasertibum
- CX-4945 (Silmitasertib)
- Silmitasertib [INN]
- Cx-4945 free acid
- CX4945
- CX 4945
- 5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid
- CX4945 (Silmitasertib)
- C6RWP0N0L2
- RefChem:6223
- Silmitasertib (CX-4945)
- C19H12ClN3O2
- UNII-C6RWP0N0L2
- MFCD13184796
- CX-4945 Silmitasertib
- D09JEJ
- Silmitasertib; CX 4945
- CX-4945 (Silmitaserib)
- CX 4945 (Silmitasertib)
- CX-4945 - Silmitasertib
- CHEMBL1230165
- cc-639
- SCHEMBL629082
- UNII-N1E607PU86
- DTXSID40143602
- SILMITASERTIB [WHO-DD]
- GTPL8126
- orb1305875
- DTXCID9066093
- SCHEMBL29381056
- SCHEMBL30193004
- CTK8B6574
- KS-00000PRB
- AOB2757
- EX-A070
- QCR-248
- SYN1109
- CHEBI:232159
- CHEBI:232617
- GLXC-04060
- HMS3244M13
- HMS3244M14
- HMS3244N13
- HMS3655F16
- HMS3746E13
- BCP02399
- ABP000327
- ANW-53685
- BDBM50335638
- NSC761193
- NSC800885
- RS0028
- RW4112
- s2248
- ZINC58638454
- AKOS005266722
- ACN-029586
- AN-1295
- BCP9000560
- CCG-264955
- CS-0563
- CX-4945/CX4945
- DB15408
- EBC-216024
- EX-8673
- FC30749
- MP-1904
- NSC-761193
- NSC-800885
- SB17201
- SDCCGSBI-0654415.P001
- 5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid
- NCGC00263192-01
- NCGC00263192-02
- NCGC00263192-09
- NCGC00263192-13
- 4CA-1158
- AC-28426
- AK-82006
- AS-16253
- BC638769
- CID:24748573
- HY-50855
- SY069677
- 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid
- SID:223258866
- 5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid
- 5-[(3-chlorophenyl)amino]benzo[c]2,6-naphthyridine-8-carboxylic acid
- AB0033729
- AJ-113170
- DB-016103
- TC-142430
- A8330
- FT-0723994
- ST24023701
- SW218157-2
- X7439
- J2.914.751E
- A11060
- A25034
- Benzo[c]-2,6-naphthyridine-8-carboxylic acid, 5-[(3-chlorophenyl)amino]-
- EN300-6482034
- 5-((3-Chlorophenyl)amino)benzo-[c][2,6]naphthyridine-8-carboxylic acid
- 5-[(3-Chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-Carboxylic Acid
- C555142
- 5-(3-chlorophenylamino)benzo(c)(2,6)naphthyridine-8-carboxylic acid
- 5-[(3-Chlorophenyl)amino]benzo[c]-2,6-naphthyridine-8-carboxylic acid
- BRD-K81458380-001-04-9
- CX-4945,CAS:1009820-21-6
- Q27076934
- B2693-286324
- 9-(3-Chloroanilino)-6,10-diazaphenanthrene-2-carboxylic acid
- CX 4945,CX4945, 1009820-21-6
- 5-((3-chlorophenyl)amino)pyrido(4,3-c)quinoline-8-carboxylic acid
- 5-[(3-chlorophenyl)amino]pyrido[4,3-c]quinoline-8-carboxylic acid
- 5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic Acid
- 5-((3-chlorophenyl)amino)benzo(c)2,6-naphthyridine-8-carboxylic acid
- Methyl 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carb oxylate
- 5-((3-CHLOROPHENYL)AMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID
- BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)-
- CX-4945|||5-(3-Chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid
- Silmitasertib, 98%, a potent and selective ATP-competitive CK2 inhibitor - 25MG 25mg
- 1009820-90-9
- 3NG